The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Q3 2025 Management View CEO Anthony Zook highlighted record clinical volumes and revenues for the third quarter of 2025, emphasizing the company’s progress in next-generation sequencing (NGS) and ...
Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...
Giovanna Prout joins Countable Labs as CEO to accelerate commercialization of Countable Labs’ products Countable Labs, the developer of Countable PCR, a category-defining PCR technology that sets a ...
LAKE FOREST, Calif. & WOODLAND PARK, N.J.--(BUSINESS WIRE)--Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today ...
The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
This study demonstrates that NGS-MSI is noninferior to IHC-MMR and can identify MSI-H tumors that IHC-MMR is unable to detect and conversely IHC-MMR can identify MMRd tumors that NGS-MSI misses. This ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback